Thyroid nodule other imaging findings: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:
** Most benign nodules
** Most benign nodules
** Most malignant thyroid nodules
** Most malignant thyroid nodules
Posttherapy whole-body iodine scanning is typically conducted approximately 1 week after RAI therapy to visualize metastases.


=== FDG-PET scan ===
=== FDG-PET scan ===
Line 31: Line 32:


There is insuffiecient evidence to recommend to or against routine clinical use
There is insuffiecient evidence to recommend to or against routine clinical use
==== Iodine 131 single photon emission computed tomography (SPECT)=CT fusion imaging ====
may provide superior lesion localization after remnant ablation, but it is still a relatively new imaging modality


==References==
==References==

Revision as of 16:27, 12 August 2017


Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Thyroid nodule Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thyroid nodule from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thyroid nodule other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thyroid nodule other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thyroid nodule other imaging findings

CDC on Thyroid nodule other imaging findings

Thyroid nodule other imaging findings in the news

Blogs on Thyroid nodule other imaging findings

Directions to Hospitals Treating Thyroid nodule

Risk calculators and risk factors for Thyroid nodule other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Other Imaging Studies

Radionuclide thyroid scan/scintigraphy

using either technetium 99 mTc pertechnetate or 123I

radionuclide scan is contraindicated during pregnancy

Thyroid scintigraphy is useful to determine the functional status of a nodule. It is specifically indicated in patients with thyroid nodule and a low serum TSH to determine if the nodule is autonomously functioning.

In scintigraphy, iodine radioisotopes (more commonly used; usually 123I) or technetium pertechnetate (99Tc), are injected to the patient and then the radioisotope uptake time by the thyroid gland is measured.4406304 16910877

  • High radioisotopes uptake=Hot nodule:
    • Hyperfunctioning nodules
  • Low radioisotopes uptake=Cold nodule:
    • Most benign nodules
    • Most malignant thyroid nodules

Posttherapy whole-body iodine scanning is typically conducted approximately 1 week after RAI therapy to visualize metastases.

FDG-PET scan

improve diagnostic accuracy of indeterminate thyroid nodules

In patients with thyroid PET incidentaloma, the incidence of primary thyroid malignancy is very high 

24902804

There is insuffiecient evidence to recommend to or against routine clinical use

Iodine 131 single photon emission computed tomography (SPECT)=CT fusion imaging

may provide superior lesion localization after remnant ablation, but it is still a relatively new imaging modality

References

Template:WH Template:WS